International Business Machines Corp’s recent filing unveils that its Director ZOLLAR ALFRED W acquired Company’s shares for reported $0.2 million on Nov 13 ’24. In the deal valued at $210.62 per share,936 shares were bought. As a result of this transaction, ZOLLAR ALFRED W now holds 936 shares worth roughly $0.24 million.
Then, LAMOREAUX NICKLE JACLYN sold 3,600 shares, generating $774,727 in total proceeds. Upon selling the shares at $215.20, the Senior Vice President now owns 25,390 shares.
Oppenheimer initiated its International Business Machines Corp [IBM] rating to an Outperform in a research note published on February 11, 2025; the price target was $320. DZ Bank also remained covering IBM and has decreased its forecast on October 02, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on June 24, 2024. It rated IBM as “a Buy”.
Price Performance Review of IBM
On Tuesday, International Business Machines Corp [NYSE:IBM] saw its stock fall -1.57% to $257.75. Over the last five days, the stock has lost -2.02%. International Business Machines Corp shares have risen nearly 17.25% since the year began. Nevertheless, the stocks have risen 39.92% over the past one year. While a 52-week high of $265.72 was reached on 02/05/25, a 52-week low of $162.62 was recorded on 01/14/25. SMA at 50 days reached $236.53, while 200 days put it at $207.91.
Levels Of Support And Resistance For IBM Stock
The 24-hour chart illustrates a support level at 255.19, which if violated will result in even more drops to 252.62. On the upside, there is a resistance level at 261.90. A further resistance level may holdings at 266.04. The Relative Strength Index (RSI) on the 14-day chart is 59.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.61, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 42.28%. Stochastics %K at 71.60% indicates the stock is a holding.
The most recent change occurred on May 02, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”an Underperform”‘ rating along with a $145 price target.
